FDA Drug recall D-1369-2012
Diazepam Injection, USP, 10 mg Automatic, Autoinjector for Buddy Use, 5 mg/mL, 2 mL autoinjector, 15-count autoinjectors per carton, Rx onl…
- FDA Drug
- Class II
- terminated
- Published 2012-06-20
On 2012-06-20 the FDA classified a Class II recall of Diazepam Injection, USP, 10 mg Automatic, Autoinjector for Buddy Use, 5 mg/mL, 2 mL autoinjector, 15-count autoinjectors per carton, Rx onl… by Meridian Medical Technologies A Pfizer, citing impurities/Degradation Products: High Out of Specification levels for carbostyril, a known degradation product of diazepam.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1369-2012 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2012-06-06 |
| Published | 2012-06-20 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Meridian Medical Technologies A Pfizer |
| Distribution | US |
Product
Diazepam Injection, USP, 10 mg Automatic, Autoinjector for Buddy Use, 5 mg/mL, 2 mL autoinjector, 15-count autoinjectors per carton, Rx only, Meridian Medical Technologies, Columbia, MD 21046; A subsidiary of King Pharmaceuticals, Inc.; NSN 6505-01-274-0951, NDC 11704-600-01.
Reason
Impurities/Degradation Products: High Out of Specification levels for carbostyril, a known degradation product of diazepam.
Identifiers
| ndc | 11704-600-01 |
|---|---|
| code_info | Lot #: 8D1082, Exp 01/13; 8D1151, Exp 03/13 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1369-2012%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.